Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
暂无分享,去创建一个
N. Takahira | M. Yamaoka-Tojo | A. Matsunaga | T. Izumi | N. Aoyama | T. Tojo | T. Masuda